Navigation Links
Elsevier Supports Russia's ROSATOM Knowledge Management Program

MOSCOW, July 15, 2013 /PRNewswire/ --

25 ROSATOM affiliated research institutes benefit from access to ScienceDirect and Scopus to support safe nuclear energy research

Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced it has extended its collaboration with Russia's State Atomic Energy Corporation (ROSATOM) by providing 25 research institutes with access to ScienceDirect and Scopus as part of its Knowledge Management Program.

Launched in 2011, ROSATOM's Knowledge Management Program offers its researchers an infrastructure to access and preserve international scientific information, supporting its development in fundamental and applied research in nuclear and radiation safety, nuclear medicine, composite materials and new energy sources. Providing access to ScienceDirect, Elsevier's full-text platform for research literature, and Scopus, the largest abstract and citation database of peer-reviewed literature, expands the ROSATOM program and will help the 25 affiliated research institutes to further develop their position in nuclear energy research.

Dr. Nikolay Kondratyev, CEO of ROSATOM's managing company CJSC Science and Innovations, said, "We recognize that it is impossible to be a leader in research and stimulate innovation without access to high-quality scientific information. We are pleased to continue our cooperation with Elsevier and are confident that including Elsevier's tools and resources in the program will help us to deliver scientific breakthroughs."

Igor Osipov, PhD, Regional Director at Elsevier for Russia and Belarus, added, "ROSATOM 's Knowledge Management Program stimulates search and discovery across its national network of Research & Development centers. We are pleased to support the program by providing access to ScienceDirect and Scopus for ROSATOM's research community. By including Elsevier's tools and resources in the program, we also take a further step in our collaboration with Russian scientific institutes."


The State Atomic Energy Corporation ROSATOM incorporates more than 250 enterprises and scientific institutions, including all civil nuclear companies of Russia, nuclear weapons complex's facilities, research organizations and the world's only nuclear-propelled fleet. ROSATOM is the largest utility in Russia which produces more than 40% of electricity in the country's European part. ROSATOM holds leading positions in the world market of nuclear technologies being the 1-st in the world simultaneous nuclear build abroad; 2-nd in uranium reserves and 5-th in uranium mining; 4-th in nuclear electricity generation, while providing 40% of the world uranium enrichment services and 17% of the world nuclear fuel market. ROSATOM is also tasked to fulfill Russia's international obligations in the field of the peaceful uses of atomic energy and nuclear nonproliferation regime.

About ScienceDirect

ScienceDirect is a world premier full-text scientific database offering journal articles and book chapters from more than 2,500 peer-reviewed journals and 11,000 books. The platform offers search and retrieval functionalities that enable users to work effectively in the knowledge discovery process. ScienceDirect aims to revolutionize the traditional format of the academic paper; interactive elements, enhanced online-readability, alerting services, and linking options to external datasets help researchers to build insights at the article level. ScienceDirect now has more than 10 million users; its wide reach makes it an ideal place for scientists to publish and disseminate their research findings.

About Scopus

Scopus, the largest abstract and citation database of peer-reviewed literature, features smart tools to track, analyze and visualize scholarly research. Its vast database contains abstracts and references from nearly 21,000 titles from 5,000 publishers worldwide, ensuring broad interdisciplinary coverage in the fields of science, technology, medicine, social sciences and Arts & Humanities. Scopus was designed and developed with input from researchers and librarians internationally; and features direct links to subscribed full-text articles, other library resources and interoperability with applications such as reference management software.

About Elsevier

Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include ScienceDirect, Scopus, Reaxys, ClinicalKey and Mosby's Suite, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai's Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group plc, a world leading provider of professional information solutions. The group employs more than 30,000 people, including more than 15,000 in North America. Reed Elsevier Group plc is owned equally by two parent companies, Reed Elsevier PLC and Reed Elsevier NV. Their shares are traded on the London, Amsterdam and New York Stock Exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RUK and ENL.

Media contact
Galina Yakshonak
Elsevier, Russia

SOURCE Elsevier
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Elsevier Supports International Crisis Aid Through Pillars of Hope Campaign
2. Elsevier / MEDai Appoints Tom Zajac as New President
3. Elsevier Collaborates with the American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.)
4. Elsevier and Federation of Biochemical Societies Launch New Journal: FEBS Open Bio
5. Elsevier Foundation Awards 2011 Grants to Advance Women in Science and Support Libraries in Developing Countries
6. Elsevier Acquires QUOSA, Provider of Life Sciences Content Management and Workflow Productivity Solutions
7. Elsevier Launches Bilingual International Nursing Skill Training and Management Platform:
8. Leading German Researcher Awarded Elseviers 2011 Tetrahedron Prize
9. Elsevier/Gold Standard Exclusive Publisher of New Predictive Drug Price Type
10. Elsevier Collaborates With Prophecy Healthcare to Enhance Its Staff Development Offerings for Healthcare Organizations
11. Elsevier Launches New Journal: Learning, Culture and Social Interaction
Post Your Comments:
(Date:11/27/2015)... 2015 --> ... companion diagnostics is one of the major ... pharmaceutical companies and diagnostic manufacturers working together ... . --> ... global cancer biomarkers market spread across 89 ...
(Date:11/25/2015)...  PharmAthene, Inc. (NYSE MKT: PIP) announced  today that ... plan (Rights Plan) in an effort to preserve the ... Section 382 of the Internal Revenue Code (Code). ... of its NOLs could be substantially limited if the ... 382 of the Code. In general, an ownership change ...
(Date:11/25/2015)... Nov. 25, 2015  Neurocrine Biosciences, Inc. (Nasdaq: ... President and CEO of Neurocrine Biosciences, will be presenting ... New York . ... website approximately 5 minutes prior to the presentation to ... the presentation will be available on the website approximately ...
(Date:11/25/2015)... November 25, 2015 The ... is a professional and in-depth study on the ...      (Logo: ) , ... industry including definitions, classifications, applications and industry chain ... the international markets including development trends, competitive landscape ...
Breaking Biology Technology:
(Date:11/16/2015)... Calif. , Nov 16, 2015  Synaptics ... of human interface solutions, today announced expansion of ... TouchView ™ touch controller and display driver ... revolution of smartphones. These new TDDI products add ... TD4100 (HD resolution), TD4302 (WQHD resolution), and TD4322 ...
(Date:11/10/2015)... , Nov. 10, 2015  In this ... the basis of product, type, application, disease ... in this report are consumables, services, software. ... are safety biomarkers, efficacy biomarkers, and validation ... report are diagnostics development, drug discovery and ...
(Date:11/2/2015)... , Nov. 2, 2015  SRI International has ... to provide preclinical development services to the National Cancer ... SRI will provide scientific expertise, modern testing and support ... of preclinical pharmacology and toxicology studies to evaluate potential ... --> The PREVENT Cancer Drug Development Program is ...
Breaking Biology News(10 mins):